-
GVS receives a “B” rating in CDP Climate Change 2024
ESG -
Sustainability Leader
ESG -
GVS Earns EcoVadis Gold Medal for the Second Consecutive Year
ESG -
GVS Announces Strategic Acquisition of Haemonetics’ Whole Blood Business
Corporate -
Announcing the GVS 2024-2026 Sustainability Plan: "Protecting Your Tomorrow"
ESG -
GVS recognized as a Sustainability Leader 2024
ESG -
GVS supports “Sport Education"
ESG -
GVS is awarded the EcoVadis Gold Medal: An Achievement of Excellence in Sustainability
ESG
News & Media
Discover the latest News about GVS
-
-
Whistleblowing Reporting Channel
Corporate -
Development of a Simple DNA Extraction Method and Diagnosis of Candidemia
Life Sciences -
Earth likes you, like it back
Corporate -
GVS acquires 100% of the Italian Group Haemotronic
Corporate -
Cosmo, the Nailstation equipped with Molecular Filter
Safety -
Twenty years of GVS Speedflow® Adult
MedTech -
GVS acquires 100% of the Shanghai Transfusion Technology Co., Ltd
Corporate -
Initiative organized by GVS for the World Day of Human Solidarity
ESG -
Segre F31000 has received a new registration as medical device
Safety -
OMICRON Invisible to some PCR Kits
Life Sciences -
GVS Flame CoViD-19 VARIANTS qPCR Master Kit and OMICRON Variant
Life Sciences -
GVS supports “Fondazione per lo Sport Silvia Parente”
ESG -
GVS acquires 100% of the RPB Group
Corporate -
GVS wins EcoVadis silver medal
ESG -
First patent for 'Infusion device with air intake' registered by GVS
Corporate -
GVS supports the “Canoa Club Bologna – CCBO”
ESG -
Membership of the United Nations Global Compact: a concrete commitment to a sustainable future
ESG -
GVS S.p.A. moves to renewable energy
ESG -
Accolade of "Cavaliere del Lavoro"
Corporate -
Una maschera può salvare una vita
Safety -
GVS Vacuum Filtration Systems
Life Sciences -
Track Etched Membrane in Life Sciences applications
Life Sciences -
Uniform Nano-filtration Membranes for reproducible results
Life Sciences -
Plasma Virus Inactivation devices
MedTech -
GVS Sud Srl collaborates in a project to develop multifunctional filters for blood treatment
Corporate -
GVS refunds the original loan of 90 million Euros in advance
Corporate -
GVS debuts on Borsa Italiana's MTA
Corporate -
GVS: IPO Ceremony at Borsa Italiana
Corporate -
GVS acquires Puerto Rico-based manufacturing operations of Haemonetics
Corporate -
GVS acquires filter product business of Graphic Controls
Corporate
